Whitepapers | ShareVault

M&A Negotiations

This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.

Best Practices & Trends Life Sciences Mergers & Acquisitions Negotiation Whitepapers

Pullan's Pieces - A Business Development View of the Oncology Landscape

In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Must-Know Finance Concepts for Life Sciences Valuations

This whitepaper presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

Best Practices & Trends BioPharma Life Sciences Valuation Whitepapers

The Nuts & Bolts of Due Diligence in Biopharma Partnering

This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships.

Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers

What's Hot and What's Not in Oncology Licensing in 2020?

In this whitepaper, Linda Pullan, PhD of Pullan Consulting and our panel of experts provided insights in oncology and immuno-oncology in 2020.

Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers

How to Win at the Partnering Game

In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.

Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers

Earnouts: Structures for Breaking Negotiation Deadlocks

This white paper features Senior M&A Executive Javier Enrile of Principal Global Investors. Mr. Enrile provides his extensive expertise to explain how earnout, (also "earn-out") structures work and how it can reduce risk for the buyer, add attractive incentives for the seller, and serve to break negotiation deadlocks and get deals consummated.

Finance Mergers & Acquisitions Negotiation Whitepapers

Precision Medicine in Central Nervous System Drug Development

Precision medicine, which has been pioneered by the field of oncology, aims to target the right treatments to the right patients at the right time.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Microbiome: Hope or Hype?

This whitepaper discusses how will microbiome impact human therapeutics, who's driving it, and why.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

National Institute of Health Small Business Programs

This guide reviews the description of the programs and goals, tips on applying, and resources available to researchers and small/startup businesses interested in translating their technologies into commercial products.

BioPharma Life Sciences Other Topics Whitepapers

The Nuts & Bolts of Selecting a Contract Research Organization

This whitepaper discusses how to determine internal champions/selection committees, strategic sourcing/Procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

M&A Integration‚ Maximizing the Return on Technology and Talent

This whitepaper delves into the web panel discussion –

"M&A Integration: Maximizing Return on Technology & Talent" addressing key areas of focus that help drive business decisions related to technology and talent.

Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers

1
2
3
4